NOIDS.wiki
Calculator
Shop Potency Calculator
Cannabis Science

HHC (Hexahydrocannabinol): What It Is, Effects & Safety

Cannabinoid · Semi-synthetic

IntoxicatingSemi-syntheticHydrogenated THCMinimal research

HHC (hexahydrocannabinol) is a semi-synthetic, intoxicating cannabinoid made by hydrogenating THC; published human research is minimal, and unregulated products vary widely in purity and potency. Adding hydrogen makes it more stable against heat and oxidation than THC. Trace amounts occur naturally, but commercial HHC is made in a lab from hemp-derived CBD or THC.

Full name
Hexahydrocannabinol
Molecular formula
C21H32O2
Molar mass
316.48 g/mol
Identifier
CAS 36403-90-4
Origin
Semi-synthetic (hydrogenated THC)
Intoxicating?
Yes
Made from
Hemp-derived CBD or THC

Why HHC exists

Stability and a legal grey area

Hydrogenation removes the double bond that makes THC prone to degrading into CBN, so HHC keeps its potency longer. It also emerged as a way to sell an intoxicating cannabinoid where hemp is legal but THC is not. There is very little published human research on HHC, and the unregulated market means purity and potency vary widely between products.

Legal and sport status

HHC’s legal status is unsettled and changing country to country. In sport, WADA exempts only CBD, so HHC is not exempt.

FAQ

Is HHC natural or synthetic? Semi-synthetic. It is made by hydrogenating THC in a lab; only trace amounts occur naturally.

Is HHC stronger than THC? Reports vary and there is little research; many users describe it as similar to or slightly milder than THC. Potency of commercial products is inconsistent.

Does HHC show up on a drug test? Possibly. Evidence is limited, but some HHC metabolites may trigger a standard THC test; do not assume it is undetectable.

Sources

  1. Hexahydrocannabinol, compound record, PubChem. pubchem.ncbi.nlm.nih.gov
  2. Novel semi-synthetic cannabinoids, EMCDDA overview. emcdda.europa.eu

C9 epimer stereochemistry and pharmacological research

Catalytic hydrogenation of delta-8- or delta-9-THC saturates the cyclohexene double bond and creates a chiral center at carbon-9, producing two epimers: (9R)-hexahydrocannabinol and (9S)-hexahydrocannabinol (Ujvary, 2023, PubMed PMID 37356888). Receptor-binding and functional assays demonstrate that the (9R)-HHC epimer acts as a partial agonist at human CB1 and CB2 receptors with potency approaching delta-9-THC, whereas the (9S)-HHC epimer displays markedly lower CB1 activity, explaining why commercial semi-synthetic cannabinoid products vary in strength according to their (9R):(9S) diastereomeric ratio (Nasrallah & Garg, 2023 / Russo et al., 2023, PubMed PMID 37689056).

Part of the NOIDS cannabinoids index. Educational reference, not medical advice.

This article is for educational purposes only. Always follow local laws regarding cannabis preparation and use.

Scroll to Top